Picamilon, 50 mg/ml 2 ml 10 pcs

Nootropic, dilates cerebral blood vessels. It has tranquilizing and mild psychostimulant effect, antiaggregant and antioxidant effect.

Indications

Adults:

• Chronic cerebrovascular insufficiency (discirculatory encephalopathy, consequences of cerebral circulation disorders), condition after craniocerebral injury, vegetative dystonia syndrome, in the complex treatment of depressive disorders of various genesis in old age.
• in complex therapy of chronic alcoholism (decrease of asthenic, asthenoneurotic, post-psychotic, pre relapse states at alcoholic encephalopathy).
• in complex therapy of primary open-angle glaucoma with compensated intraocular pressure (for stabilization of visual function).
• in complex therapy of vegetative dystonia syndrome, accompanied by anxiety, fear, increased irritability, asthenia, emotional lability.
• to improve the tolerance of physical and mental stress, and to increase the resistance to stress (for people who are in stressful and extreme conditions of activity, to restore the physical performance of athletes, to increase the resistance to physical and mental stress).

In children over 3 years of age and adults in urological practice in urinary disorders to improve the adaptive function of the bladder (decrease detrusor hypoxia).

Active ingredient

Nicotinoyl gamma-aminobutyric acid

How to take, the dosage

Intravenous drip or stream (slowly), intramuscularly.

Interaction

Shortens the effect of barbiturates, increases the effect of narcotic analgesics.

Special Instructions

The drug may have a negative effect on potentially dangerous activities requiring special attention and reaction time (driving a car, operating moving mechanisms, etc.).

Contraindications

Hypersensitivity, chronic renal insufficiency, pregnancy, lactation, children under 3 years of age (in children over 3 years of age, used for urinary disorders).

Side effects

Decreased blood pressure, dizziness, headache, mild nausea, irritability, agitation, anxiety, allergic reactions (skin rash, itching).

Overdose

Increased expression of dose-dependent symptoms of adverse reactions. Treatment is symptomatic.